20Apr
Related Posts
07Jun
Novonix (ASX:NVX) and LG Energy Solution enter into US$30m investment agreement
07 Jun 2023 - Novonix Limited (ASX:NVX) CEO Dr Chris Burns discusses the company's joint research and development agreement with South Korean battery cell manufacturer LG Energy Solution.
Read More
06Feb
Altech Batteries unveils prototype update, nearing final testing phase
06 Feb 2024 - Altech Batteries (ASX:ATC) reveals prototype, poised for final tests and government backing.
Read More
27Sep
Market update with Shaw and Partners, September 2024
27 Sep 2024 - Martin Crabb, Chief Investment Officer at Shaw and Partners, speaks on the mixed market outlook. He discusses growth, financial conditions, central bank policies and valuations. He advocates for a cautious approach focused on stock picking in the current climate, favouring small caps over large caps.
Read More
13Aug
Technology as the turning point of civilisations
13 Aug 2025 - Sovereign Advisors Principal Advisor Zaheer Lalani and Investment Manager Max Riaz provide a quarterly update on the markets.
Read More
16Sep
AdAlta (ASX:1AD) targeting idiopathic pulmonary fibrosis
16 Sep 2019 - AdAlta Limited (ASX:1AD) Executive Chairman, Dr Paul MacLeman talks about the company's collaboration with GE Healthcare.
Read More
23Sep
AD1 Holdings (ASX:AD1) FY21 results and outlook
23 Sep 2021 - AD1 Holdings Limited (ASX:AD1) CEO and Managing Director Brendan Kavenagh provides an update on the company's suite of software as a service businesses, FY21 results and outlook.
Read More
21Sep
RIU Good Oil & Gas Conference Q&A – Alex Parks of Prominence Energy (ASX:PRM)
21 Sep 2023 - Alex Parks - CEO and Managing Director - Prominence Energy (ASX:PRM) is an ASX listed oil and gas exploration and development company.
Read More
29Feb
2024 RIU Explorers Conference Q&A with Murray Hill of Elevate Uranium
29 Feb 2024 - Murray Hill - Managing Director & CEO - Elevate Uranium (ASX:EL8) is a uranium exploration company that has significant resources in Namibia and Australia and is making new discoveries through active exploration programs.
Read More
07Jun
Chimeric Therapeutics (ASX:CHM) clinical stage T cell therapy biotech targeting glioblastoma
07 Jun 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's phase 1 trial results for its chlorotoxin CAR T (CLTX CAR T) cell therapy targeting glioblastoma.
Read More
30Nov
Novatti Group (ASX:NOV) partnering with UnionPay, Google Pay & Samsung Pay
27 Nov 2020 - Novatti Group Limited (ASX:NOV) Managing Director & CEO Peter Cook talks about the company's recently announced partnerships with UnionPay, Google Pay and Samsung Pay.
Read More